Home/Filings/4/0001483813-13-000022
4//SEC Filing

Frost Gregory Ian 4

Accession 0001483813-13-000022

CIK 0001159036other

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 7:00 PM ET

Size

7.4 KB

Accession

0001483813-13-000022

Insider Transaction Report

Form 4
Period: 2013-02-04
Frost Gregory Ian
DirectorVP and Chief Scientific Off.
Transactions
  • Award

    Option to Purchase Common Stock

    2013-02-04$6.55/sh+65,000$425,75065,000 total
    Exercise: $6.55Exp: 2023-02-04Common Stock (65,000 underlying)
  • Award

    Restricted Stock Units

    2013-02-04+39,00039,000 total
    Exercise: $0.00Exp: 2023-02-04Common Stock (39,000 underlying)
Footnotes (2)
  • [F1]This option vests one-fourth on such date and then 1/48 monthly thereafter.
  • [F2]This award vests one-fourth on such date and then one-fourth on each anniversary thereafter.

Issuer

HALOZYME THERAPEUTICS INC

CIK 0001159036

Entity typeother

Related Parties

1
  • filerCIK 0001283518

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 7:00 PM ET
Size
7.4 KB